NEW YORK (GenomeWeb) – Metamark today announced that its Cambridge, Mass., laboratory has received accreditation from the College of American Pathologists.

The lab will be the primary facility for processing the company's ProMark protein-biopsy test to aid physicians and prostate cancer patients select the most appropriate treatment options. The test generates a score and is targeted to the 85 percent of patients with biopsy Gleason grades of 3+3 or 3+4 for whom current standard-of-care tests may offer unclear guidance, the Cambridge-based firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.